Company intelligence / Profile preview
Immtech Pharmaceuticals, Inc.
Vernon Hills, Illinois, United Statesimmtechpharma.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Immtech Pharmaceuticals developed a proprietary dication-based small molecule platform with lead candidates targeting malaria, African sleeping sickness, Pneumocystis pneumonia, tuberculosis, fungal infections and resistant bacterial pathogens. Their most advanced candidate was pafuramidine maleate (DB289) for malaria and trypanosomiasis. However, all known clinical programs were ultimately discontinued due to efficacy/safety issues or strategic reasons; the company appears inactive with no current pipeline activity reported since mid-late2000s.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculesRecombinant proteinsMonoclonal antibodies (in partnership/distribution context)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Medicines for Malaria Venture(MMV )University of North Carolina at Chapel Hill(UNC–CH )
Beyond the preview
Go deeper on Immtech Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immtech Pharmaceuticals, Inc..